Literature DB >> 16738042

Insights into post-infectious bronchiolitis obliterans in children.

K J Smith, L L Fan.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16738042      PMCID: PMC2111231          DOI: 10.1136/thx.2005.052670

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  24 in total

Review 1.  Small airways diseases: detection and insights with computed tomography.

Authors:  D M Hansell
Journal:  Eur Respir J       Date:  2001-06       Impact factor: 16.671

2.  State of the art: bronchiolitis.

Authors:  M E Wohl; V Chernick
Journal:  Am Rev Respir Dis       Date:  1978-10

3.  Unilateral hyperlucent lung syndrome in children.

Authors:  G R Cumming; R I Macpherson; V Chernick
Journal:  J Pediatr       Date:  1971-02       Impact factor: 4.406

4.  Bronchopneumonia with serious sequelae in children with evidence of adenovirus type 21 infection.

Authors:  W R Lang; C W Howden; J Laws; J F Burton
Journal:  Br Med J       Date:  1969-01-11

5.  Chronic pulmonary complications of early influenza virus infection in children.

Authors:  L R Laraya-Cuasay; A DeForest; D Huff; H Lischner; N N Huang
Journal:  Am Rev Respir Dis       Date:  1977-10

6.  Bronchiolitis obliterans in the 1990s in Korea and the United States.

Authors:  C K Kim; S W Kim; J S Kim; Y Y Koh; A H Cohen; R R Deterding; C W White
Journal:  Chest       Date:  2001-10       Impact factor: 9.410

7.  Cryptogenic obliterative bronchiolitis in adults.

Authors:  C W Turton; G Williams; M Green
Journal:  Thorax       Date:  1981-11       Impact factor: 9.139

8.  Bronchiolitis obliterans, bronchiectasis, and other sequelae of adenovirus type 21 infection in young children.

Authors:  D M Becroft
Journal:  J Clin Pathol       Date:  1971-02       Impact factor: 3.411

9.  Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis.

Authors:  A J Colom; A M Teper; W M Vollmer; G B Diette
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

10.  Chronic lung damage caused by adenovirus type 7: a ten-year follow-up study.

Authors:  S Similä; O Linna; P Lanning; E Heikkinen; M Ala-Houhala
Journal:  Chest       Date:  1981-08       Impact factor: 9.410

View more
  5 in total

1.  Clinical features of postinfectious bronchiolitis obliterans in children undergoing long-term nebulization treatment.

Authors:  Xiao-Mei Zhang; Ai-Zhen Lu; Hao-Wei Yang; Li-Ling Qian; Li-Bo Wang; Xiao-Bo Zhang
Journal:  World J Pediatr       Date:  2018-09-29       Impact factor: 2.764

Review 2.  Postinfectious Bronchiolitis Obliterans in Children: Diagnostic Workup and Therapeutic Options: A Workshop Report.

Authors:  Silvija-Pera Jerkic; Folke Brinkmann; Alistair Calder; Alicia Casey; Megan Dishop; Matthias Griese; Geoffrey Kurland; Mandy Niemitz; Sylvia Nyilas; Dirk Schramm; Ralf Schubert; Michael Tamm; Stefan Zielen; Martin Rosewich
Journal:  Can Respir J       Date:  2020-01-30       Impact factor: 2.409

3.  Epigenetic regulation of inflammation by microRNAs in post-infectious bronchiolitis obliterans.

Authors:  Ruth P Duecker; Ines De Mir Messa; Silvija-Pera Jerkic; Annalena Kochems; Gabriele Gottwald; Antonio Moreno-Galdó; Martin Rosewich; Lucia Gronau; Stefan Zielen; Andreas Geburtig-Chiocchetti; Hermann Kreyenberg; Ralf Schubert
Journal:  Clin Transl Immunology       Date:  2022-02-21

Review 4.  Viral etiology of hospitalized acute lower respiratory infections in children under 5 years of age -- a systematic review and meta-analysis.

Authors:  Ivana Lukšić; Patrick K Kearns; Fiona Scott; Igor Rudan; Harry Campbell; Harish Nair
Journal:  Croat Med J       Date:  2013-04       Impact factor: 1.351

5.  Calprotectin as a New Sensitive Marker of Neutrophilic Inflammation in Patients with Bronchiolitis Obliterans.

Authors:  S P Jerkic; F Michel; H Donath; E Herrmann; R Schubert; M Rosewich; S Zielen
Journal:  Mediators Inflamm       Date:  2020-05-01       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.